(Q48686008)

14 February 2018

title

Combined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: the potential for increased radiation toxicity. (English)

1 reference

14 February 2018

adaptive radiation therapy

main subject

0 references

author name string

Lisa J Hazard

series ordinal

1

1 reference

14 February 2018

William T Sause

series ordinal

2

1 reference

14 February 2018

R Dirk Noyes

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 March 2002

1 reference

14 February 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

14 February 2018

volume

52

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

796-800

1 reference

14 February 2018

Medical management of stage IV malignant melanoma. Medical issues

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

Brachial plexopathy after postoperative radiotherapy of breast cancer patients--a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

The combined effect of interferon beta and radiation on five human tumor cell lines and embryonal lung fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

Natural alpha-interferon in combination with hyperfractionated radiotherapy in the treatment of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

Interferon combined with irradiation in the treatment of operable head and neck carcinoma. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

A phase I pilot study of pelvic radiation and alpha-2A interferon in patients with locally advanced or recurrent rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2902700-6

7 January 2021

10.1016/S0360-3016(01)02700-6

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018